Latest Insider Transactions at 2seventy Bio, Inc. (TSVT)
This section provides a real-time view of insider transactions for 2seventy Bio, Inc. (TSVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 2seventy bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 2seventy bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,230
-0.36%
|
$4,920
$4.65 P/Share
|
|
Oct 03
2024
|
Jessica Snow |
SELL
Open market or private sale
|
Direct |
679
-0.43%
|
$2,716
$4.65 P/Share
|
|
Aug 14
2024
|
Jessica Snow |
SELL
Open market or private sale
|
Direct |
7,816
-4.76%
|
$31,264
$4.32 P/Share
|
|
Aug 05
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13
-0.0%
|
$39
$3.98 P/Share
|
|
Jul 02
2024
|
Jessica Snow |
SELL
Open market or private sale
|
Direct |
14
-0.01%
|
$56
$4.02 P/Share
|
|
Jul 02
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12
-0.0%
|
$48
$4.02 P/Share
|
|
Jul 01
2024
|
Jessica Snow |
BUY
Grant, award, or other acquisition
|
Direct |
108,538
+39.8%
|
-
|
|
Jul 01
2024
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
586,022
+39.58%
|
-
|
|
Jul 01
2024
|
Victoria Eatwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
245,864
+41.87%
|
-
|
|
Jun 10
2024
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
12,050
+27.63%
|
-
|
|
Jun 10
2024
|
Charles W. Newton |
BUY
Grant, award, or other acquisition
|
Direct |
6,025
+21.03%
|
-
|
|
Jun 10
2024
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
12,050
+30.35%
|
-
|
|
Jun 10
2024
|
Lin Wei |
BUY
Grant, award, or other acquisition
|
Direct |
12,050
+26.84%
|
-
|
|
Jun 10
2024
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
12,050
+30.35%
|
-
|
|
Jun 10
2024
|
Casdin Capital, LLC Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,025
+21.03%
|
-
|
|
Jun 03
2024
|
Jessica Snow |
SELL
Open market or private sale
|
Direct |
649
-1.15%
|
$2,596
$4.18 P/Share
|
|
Jun 03
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,167
-1.21%
|
$4,668
$4.18 P/Share
|
|
May 03
2024
|
Jessica Snow |
SELL
Open market or private sale
|
Direct |
15
-0.03%
|
$60
$4.91 P/Share
|
|
Apr 01
2024
|
Jessica Snow |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+35.7%
|
-
|
|
Apr 01
2024
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,250
+15.42%
|
-
|
|
Apr 01
2024
|
Victoria Eatwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+30.54%
|
-
|
|
Mar 26
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
40,000
+1.96%
|
$200,000
$5.1 P/Share
|
|
Mar 25
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
330,000
+14.41%
|
$1,650,000
$5.07 P/Share
|
|
Mar 22
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
147,377
+8.29%
|
$736,885
$5.12 P/Share
|
|
Mar 21
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+16.83%
|
$1,200,000
$4.9 P/Share
|
|
Mar 20
2024
|
Charles W. Newton |
BUY
Grant, award, or other acquisition
|
Direct |
16,600
+50.0%
|
-
|
|
Jan 08
2024
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
91,000
+26.5%
|
-
|
|
Jan 08
2024
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
235,000
+15.11%
|
-
|
|
Jan 08
2024
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,438
+20.38%
|
-
|
|
Jan 05
2024
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
1,380
-0.85%
|
$4,140
$3.75 P/Share
|
|
Jan 05
2024
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
1,554
-0.14%
|
$4,662
$3.75 P/Share
|
|
Jan 05
2024
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
795
-0.34%
|
$2,385
$3.75 P/Share
|
|
Jan 03
2024
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
33,651
-17.14%
|
$100,953
$3.87 P/Share
|
|
Jan 03
2024
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,613
-9.96%
|
$76,839
$3.87 P/Share
|
|
Jan 03
2024
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
72,312
-6.24%
|
$216,936
$3.87 P/Share
|
|
Aug 22
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
9,312
-0.8%
|
$46,560
$5.49 P/Share
|
|
Aug 22
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
7,031
-3.46%
|
$35,155
$5.49 P/Share
|
|
Aug 22
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,159
-2.34%
|
$30,795
$5.49 P/Share
|
|
Aug 10
2023
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
515,414
+1.78%
|
$2,577,070
$5.9 P/Share
|
|
Aug 10
2023
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
86,414
+1.65%
|
$432,070
$5.96 P/Share
|
|
Aug 10
2023
|
Kynam Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
515,414
+1.78%
|
$2,577,070
$5.9 P/Share
|
|
Aug 10
2023
|
Kynam Capital Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
86,414
+1.65%
|
$432,070
$5.96 P/Share
|
|
Aug 03
2023
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
6,906
-3.28%
|
$41,436
$6.13 P/Share
|
|
Aug 03
2023
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,966
-1.48%
|
$23,796
$6.13 P/Share
|
|
Aug 03
2023
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
9,060
-0.77%
|
$54,360
$6.13 P/Share
|
|
Jun 13
2023
|
Lin Wei |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+16.8%
|
-
|
|
Jun 13
2023
|
Daniel Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.52%
|
-
|
|
Jun 13
2023
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+35.0%
|
-
|
|
Jun 13
2023
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+35.0%
|
-
|
|
Jun 13
2023
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+30.1%
|
-
|